Newsbenzinga
BioXcel Therapeutics Files Chapter 11 Bankruptcy, Estimates Liabilities Up To $500M Versus Assets As Low As $10M
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…